23  Called-up share capital

Group and Company

2009

Number

2008

Number

2009

£’000

2008

£’000

Authorised

Ordinary shares of 1p

125,000,000

125,000,000

1,250

1,250

Issued and fully paid

Ordinary shares of 1p

At 1 July

93,478,980

93,478,980

935

935

Allotted on exercise of share options

66,257

–

1

–

Shares issued

2,356,521

–

23

–

Shares issued in settlement of deferred consideration

433,690

–

4

–

Institutional placing

7,000,000

–

70

–

At 30 June

103,335,448

93,478,980

1,033

935

See note 25 for details of share options and warrants over ordinary shares.

The Company issued 433,690 ordinary 1p shares on 31 July 2008. The shares were issued in settlement of deferred consideration relating to the acquisition of Groupe CS Dermatologie at 35p per share giving rise to a share premium of £153,255.

On 8 December the Company issued 7,000,000 ordinary 1p shares as part of an Institutional placing at 16p per share for cash consideration of £1,120,000 giving rise to a share premium of £1,050,000.

The Company also issued 66,257 ordinary 1p shares on exercise of performance share awards by employees during the year. The price paid was 1p for each share, realising cash consideration of £663.

The Company issued 2,356,521 shares to certain Directors at 23p per share for cash consideration of £542,000 giving rise to a share premium of £518,435.